Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis

被引：16

作者：

Agarwal, Aniruddha ^{[1
]}

Agrawal, Rupesh ^{[2
,3
,4
,5
]}

Raje, Dhananjay ^{[6
]}

Testi, Ilaria ^{[5
]}

Mahajan, Sarakshi ^{[7
]}

Gunasekeran, Dinesh Visva ^{[2
,3
]}

Aggarwal, Kanika ^{[6
]}

Murthy, Somasheila, I ^{[8
,9
]}

Westcott, Mark ^{[5
,6
]}

Chee, Soon-Phaik ^{[2
,4
,10
,11
,12
]}

Mccluskey, Peter ^{[13
]}

Ho, Su Ling ^{[3
]}

Teoh, Stephen ^{[3
]}

Cimino, Luca ^{[14
]}

Biswas, Jyotirmay ^{[15
]}

Narain, Shishir ^{[16
]}

Agarwal, Manisha ^{[17
]}

Mahendradas, Padmamalini ^{[18
]}

Khairallah, Moncef ^{[19
]}

Jones, Nicholas ^{[20
]}

Tugal-Tutkun, Ilknur ^{[21
]}

Babu, Kalpana ^{[22
]}

Basu, Soumayava ^{[23
]}

Carreno, Ester ^{[24
]}

Lee, Richard ^{[5
]}

Al-Dhibi, Hassan ^{[25
]}

Bodaghi, Bahram ^{[26
]}

Invernizzi, Alessandro ^{[27
]}

Goldstein, Debra A. ^{[28
]}

Herbort, Carl P. ^{[29
,30
]}

Barisani-Asenbauer, Talin ^{[31
]}

Gonzalez-Lopez, Julio J. ^{[32
]}

Androudi, Sofia ^{[33
]}

Bansal, Reema ^{[1
]}

Moharana, Bruttendu ^{[1
]}

Degli Esposti, Simona ^{[5
]}

Tasiopoulou, Anastasia ^{[5
]}

Nadarajah, Sengal ^{[5
]}

Agarwal, Mamta ^{[15
]}

Abraham, Sharanya ^{[15
]}

Vala, Ruchi ^{[18
]}

Singh, Ramandeep ^{[1
]}

Sharma, Aman ^{[34
]}

Sharma, Kusum ^{[35
]}

Zierhut, Manfred ^{[36
]}

Kon, Onn Min ^{[37
]}

Cunningham, Emmett T. ^{[38
]}

Kempen, John H. ^{[39
,40
,41
]}

Quan Dong Nguyen ^{[8
]}

Pavesio, Carlos ^{[5
]}

机构：

[1] Postgrad Inst Med Educ & Res PGIMER, Adv Eye Ctr, Chandigarh, India

[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore

[3] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore, Singapore

[4] Singapore Eye Res Inst, Dept Ophthalmol, Singapore, Singapore

[5] NHS Fdn Trust, Moorfields Eye Hosp, Dept Ophthalmol, London, England

[6] UCL Inst Ophthalmol, Dept Stat, London, England

[7] MDS Bioanalyt, Dept Ophthalmol, Nagpur, India

[8] Stanford Univ, Byres Eye Inst, Palo Alto, CA 94304 USA

[9] LV Prasad Eye Inst, Tej Kohli Cornea Inst, Dept Ophthalmol, Kallam Anji Reddy Campus, Hyderabad, India

[10] Singapore Natl Eye Ctr, Singapore, Singapore

[11] Duke NUS Med Sch, Dept Ophthalmol, Singapore, Singapore

[12] Duke NUS Med Sch, Visual Sci Acad Clin Program, Singapore, Singapore

[13] Univ Sydney, Cent Clin Sch, Save Sight Inst, Dept Clin Ophthalmol & Eye Hlth, Sydney, NSW, Australia

[14] Azienda USL IRCCS, Ocular Immunol Unit, Reggio, Italy

[15] Sankara Nethralaya, Dept Ophthalmol, Chennai, Tamil Nadu, India

[16] Shroff Eye Ctr, Dept Ophthalmol, New Delhi, India

[17] Dr Shroffs Char Eye Hosp Daryaganj, Dept Ophthalmol, New Delhi, India

[18] Narayana Nethralaya, Dept Uveitis & Ocular Immunol, Bangalore, Karnataka, India

[19] Univ Monastir, Fattouma Bourguiba Univ Hosp, Fac Med, Dept Ophthalmol, Monastir, Tunisia

[20] Univ Manchester, Dept Ophthalmol, Manchester, Lancs, England

[21] Istanbul Univ, Istanbul Fac Med, Dept Ophthalmol, Istanbul, Turkey

[22] Vittala Int Inst Ophthalmol, Prabha Eye Clin & Res Ctr, Bangalore, Karnataka, India

[23] LV Prasad Eye Inst, Dept Ophthalmol, Bhubaneswar, India

[24] Hosp Univ Fdn Jimenez Diaz, Dept Ophthalmol, Madrid, Spain

[25] King Khalid Eye Specialist Hosp, Dept Ophthalmol, Riyadh, Saudi Arabia

[26] Sorbonne Univ, Dept Ophthalmol, DHU SightRestore, Paris, France

[27] Univ Milan, Luigi Sacco Hosp, Dept Biomed & Clin Sci L Sacco, Eye Clin, Milan, Italy

[28] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA

[29] Ctr Ophthalm Specialised Care, Dept Ophthalmol, Lausanne, Switzerland

[30] Univ Lausanne, Lausanne, Switzerland

[31] Med Univ Vienna, Laura Bassi Ctr Expertise Ctr Pathophysiol Infect, Ctr Ocular Inflammat & Infect OCUVAC, Vienna, Austria

[32] Ramon Y Cajal Univ Hosp, Dept Ophthalmol, Madrid, Spain

[33] Univ Thessaly, Dept Ophthalmol, Thessaly, Greece

[34] PGIMER, Dept Rheumatol, Chandigarh, India

[35] PGIMER, Dept Microbiol, Chandigarh, India

[36] Univ Tubingen, Ctr Ophthalmol, Dept Ophthalmol, Tubingen, Germany

[37] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Chest & Allergy Clin, London, England

[38] UCSF Sch Med, Francis I Proctor Fdn, San Francisco, CA USA

[39] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA 02115 USA

[40] MyungSung Christian Med Ctr, MCM Eye Unit, Addis Ababa, Ethiopia

[41] MyungSung Med Sch, Addis Ababa, Ethiopia

来源：

OCULAR IMMUNOLOGY AND INFLAMMATION | 2020年 / 28卷

关键词：

Ocular tuberculosis; uveitis; antitubercular therapy; tuberculous; tubercular uveitis; cure; Collaborative Ocular Tuberculosis Study (COTS) group; UVEITIS;

D O I：

10.1080/09273948.2020.1761401

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Purpose To report the clinical findings, anatomical features, and treatment outcomes in subjects with ocular tuberculosis (OTB) at 24 months in the Collaborative Ocular Tuberculosis Study (COTS)-1. Methods Of the 945 subjects included in COTS-1, those who completed a 24-month follow-up after completion of treatment were included. The main outcome measure was a number of patients with treatment failure (TF). Results 228 subjects (120 males; mean age of 42.82 +/- 14.73 years) were included. Most common phenotype of uveitis was posterior (n= 81; 35.53%), and panuveitis (n= 76; 33.33%). Fifty-two patients (22.81%) had TF. On univariable analysis, odds of high TF was observed with bilaterality (OR: 3.46,p= .003), vitreous haze (OR: 2.14,p= .018), and use of immunosuppressive therapies (OR: 5.45,p= .003). However, only bilaterality was significant in the multiple regression model (OR: 2.84;p= .02). Conclusions Majority of subjects (>75%) achieved cure in the COTS-1 at 24-month follow-up. The concept of "cure" may be a valuable clinical endpoint in trials for OTB.

引用

页码：65 / 73

页数：9

共 20 条

[1] The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends
Agarwal, Aniruddha
Agrawal, Rupesh
Gunasekaran, Dinesh Visva
Raje, Dhananjay
Gupta, Bhaskar
Aggarwal, Kanika
Murthy, Somasheila L.
Westcott, Mark
Chee, Soon Phaik
McCluskey, Peter
Ling, Ho Su
Teoh, Stephen
Cimino, Luca
Biswas, Jyotirmay
Narain, Shishir
Agarwal, Manisha
Mahendradas, Padmamalini
Khairallah, Moncef
Jones, Nicholas
Tugal-Tutkun, Ilknur
Babu, Kalpana
Basu, Soumayava
Carreno, Ester
Lee, Richard
Al-Dhibi, Hassan
Bodaghi, Bahram
Invernizzi, Alessandro
Goldstein, Debra A.
Herbort, Carl P.
Barisani-Asenbauer, Talin
Gonzalez-Lopez, Julio J.
Androudi, Sofia
Bansal, Reema
Moharana, Bruttendu
Mahajan, Sarakshi
Esposti, Simona
Tasiopoulou, Anastasia
Nadarajah, Sengal
Agarwal, Mamta
Abraham, Sharanya
Vala, Ruchi
Singh, Ramandeep
Sharma, Aman
Sharma, Kusum
Zierhut, Manfred
Kon, Onn Min
Cunningham, Emmett
Quan Dong Nguyen
Pavesio, Carlos
Gupta, Vishali
[J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (03) : 465 - 473
[2] AGRAWAL R, 2020, OCUL IMMUNOL IN 0404, DOI DOI 10.1016/j.ophtha.2020.01.008
[3] Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop
Agrawal, Rupesh
Agarwal, Aniruddha
Jabs, Douglas A.
Kee, Aera
Testi, Ilaria
Mahajan, Sarakshi
McCluskey, Peter J.
Gupta, Amod
Palestine, Alan
Denniston, Alastair
Banker, Alay
Invernizzi, Alessandro
Fonollosa, Alex
Sharma, Aman
Kumar, Amitabh
Curi, Andre
Okada, Annabelle
Schlaen, Ariel
Heiligenhaus, Arnd
Kumar, Atul
Gurbaxani, Avinash
Bodaghi, Bahram
Shah, Bulbul Islam
Lowder, Careen
Tappeiner, Christoph
Muccioli, Cristina
Vasconcelos-Santos, Daniel Vitor
Goldstein, Debra
Behra, Digambar
Das, Dipankar
Makhoul, Dorine
Baglivo, Edoardo
Denisova, Ekaterina
Miserocchi, Elisabetta
Carreno, Ester
Asyari, Fatma
Pichi, Francesco
Sen, H. Nida
Uy, Harvey
Nascimento, Heloisa
Tugal-Tutkun, Ilknur
Arevalo, J. Fernando
Davis, Janet
Thorne, Jennifer
Yamamoto, Joyce Hisae
Smith, Justine
Garweg, Justus G.
Biswas, Jyotirmay
Babu, Kalpana
Aggarwal, Kanika
[J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2020, 28 : 74 - 84
[4] Global Variations and Challenges With Tubercular Uveitis in the Collaborative Ocular Tuberculosis Study
Agrawal, Rupesh
Gunasekeran, Dinesh Visva
Raje, Dhananjay
Agarwal, Aniruddha
Quan Dong Nguyen
Kon, Onn Min
Pavesio, Carlos
Gupta, Vishali
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (10) : 4162 - 4171
[5] Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1
Agrawal, Rupesh
Gunasekeran, Dinesh Visva
Grant, Robert
Agarwal, Aniruddha
Kon, Onn Min
Quan Dong Nguyen
Pavesio, Carlos
Gupta, Vishali
[J]. JAMA OPHTHALMOLOGY, 2017, 135 (12) : 1318 - 1327
[6] Tuberculosis or sarcoidosis: Opposite ends of the same disease spectrum?
Agrawal, Rupesh
Kee, Ae Ra
Ang, Leslie
Hang, Yeo Tun
Gupta, Vishali
Kon, Onn Min
Mitchell, Donald
Zierhut, Manfred
Pavesio, Carlos
[J]. TUBERCULOSIS, 2016, 98 : 21 - 26
[7] The Multicenter Uveitis Steroid Treatment Trial: Rationale, Design, and Baseline Characteristics
Kempen, John H.
Altaweel, Michael M.
Holbrook, Janet T.
Jabs, Douglas A.
Sugar, Elizabeth A.
[J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (04) : 550 - 561
[8] Bansal S, 2018, INT CONF SPEECH DATA, P1, DOI 10.1109/ICSDA.2018.8693013
[9] Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis
Basu S.
Monira S.
Modi R.R.
Choudhury N.
Mohan N.
Padhi T.R.
Balne P.K.
Sharma S.
Panigrahi S.R.
[J]. Journal of Ophthalmic Inflammation and Infection, 4 (1) : 1 - 5
[10] Uveitis: A potentially blinding disease
Durrani, OM
Meads, CA
Murray, PI
[J]. OPHTHALMOLOGICA, 2004, 218 (04) : 223 - 236

← 1 2 →